Видео ютуба по тегу Monarche

MonarchE Trial
MonarchE Trial
Исследование MonarchE – взгляд теоретика
Исследование MonarchE – взгляд теоретика
CDK4/6 for HR+ early breast cancer: monarchE results
CDK4/6 for HR+ early breast cancer: monarchE results
Исследование MonarchE – взгляд практика
Исследование MonarchE – взгляд практика
CDK4/6 nella pratica clinica: novità rilevanti dal monarchE
CDK4/6 nella pratica clinica: novità rilevanti dal monarchE
5-year monarchE results: abemaciclib + ET in high-risk EBC
5-year monarchE results: abemaciclib + ET in high-risk EBC
MonarchE 4-year: abemaciclib + endocrine therapy for HR+, HER2-, node-positive, high-risk early BC
MonarchE 4-year: abemaciclib + endocrine therapy for HR+, HER2-, node-positive, high-risk early BC
Monarch® 1138 Loading & Maintenance Instructions
Monarch® 1138 Loading & Maintenance Instructions
monarchE: patient-reported outcomes
monarchE: patient-reported outcomes
4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC
4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC
The New Monarchs Song...
The New Monarchs Song...
MonarchE results: Abemaciclib plus endocrine therapy in high-risk early breast cancer
MonarchE results: Abemaciclib plus endocrine therapy in high-risk early breast cancer
ESMO24 Spotlight: Patient-level analysis of the monarchE and NATALEE trial
ESMO24 Spotlight: Patient-level analysis of the monarchE and NATALEE trial
Age-stratified findings from the monarchE trial of abemaciclib in breast cancer
Age-stratified findings from the monarchE trial of abemaciclib in breast cancer
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer
monarchE: adjuvant abemaciclib in HR+ breast cancer
monarchE: adjuvant abemaciclib in HR+ breast cancer
monarchE: adjuvant abemaciclib + endocrine therapy in patients with HR+, HER2- high-risk eBC
monarchE: adjuvant abemaciclib + endocrine therapy in patients with HR+, HER2- high-risk eBC
Erika Hamilton, MD, considers the comparison between the monarchE and PALLAS clinical trials
Erika Hamilton, MD, considers the comparison between the monarchE and PALLAS clinical trials
𝙼𝚘𝚗𝚊𝚛𝚌𝚑𝚢 - 𝙻𝚒𝚝𝚝𝚕𝚎 𝙳𝚊𝚛𝚔 𝙰𝚐𝚎
𝙼𝚘𝚗𝚊𝚛𝚌𝚑𝚢 - 𝙻𝚒𝚝𝚝𝚕𝚎 𝙳𝚊𝚛𝚔 𝙰𝚐𝚎